Surface Oncology Accounts Payable

Surface Oncology (SURF) currently reports a accounts payable of $610K as of June 2023. That compares with $490K in the prior-year period — up 25.3% year over year. Use the charts on this page to explore Surface Oncology's accounts payable history and peer comparisons.

Surface Oncology's accounts payable increased from $490K to $610K — a 25.3% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Surface Oncology reported $610K in accounts payable as of June 2023. That compares with $490K in the prior-year period — up 25.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $610K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Surface Oncology, and consider following SURF for alerts when major investors trade the stock.

Surface Oncology is classified in the Healthcare sector. On accounts payable, it currently shows $610K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SURF with unrelated industries.